首页> 美国卫生研究院文献>Molecular Medicine Reports >Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways
【2h】

Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways

机译:N-myc下游调节基因1的过表达抑制人神经胶质瘤通过磷酸肌醇3-激酶/ AKT途径的增殖和入侵。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

N-myc downstream-regulated gene 1 (NDRG1) was previously shown to exhibit low expression in glioma tissue as compared with that in normal brain tissue; however, the role of NDRG1 in human glioma cells has remained to be elucidated. The present study used the U87 MG and SHG-44 human glioma cell lines as well as the normal human astrocyte cell line 1800, which are known to have differential NDRG1 expression. Small interfering (si)RNA targeting NDRG1, and NDRG1 overexpression vectors were transfected into the SHG-44 and U87 MG glioma cells, respectively. Cell proliferation, invasion, apoptosis and cell cycle arrest were subsequently examined by MTT assay, transwell chamber assay, flow cytometry and western blot analysis, respectively. Furthermore, a subcutaneous tumor mouse model was used to investigate the effects of NDRG1 on the growth of glioma cells in vivo. Overexpression of NDRG1 was shown to inhibit cell proliferation and invasion, and induce apoptosis in the U87 MG glioma cells, whereas NDRG1 downregulation increased proliferation, suppressed apoptosis and promoted invasion of the SHG-44 glioma cells. In addition, in the subcutaneous tumor mouse model, overexpression of NDRG1 in U-87 MG cells suppressed tumorigenicity in vivo. The findings of the present study indicated that NDRG1 is required for the inhibition of gliomagenesis; therefore, targeting NDRG1 and its downstream targets may represent novel therapies for the treatment of glioma.
机译:N-myc下游调节基因1(NDRG1)先前已显示在胶质瘤组织中的表达低于正常脑组织。然而,NDRG1在人类神经胶质瘤细胞中的作用仍有待阐明。本研究使用了已知有差异NDRG1表达的U87 MG和SHG-44人神经胶质瘤细胞系以及正常人星形胶质细胞系1800。将靶向NDRG1和NDRG1过表达载体的小干扰(si)RNA分别转染到SHG-44和U87 MG神经胶质瘤细胞中。随后分别通过MTT测定法,transwell室测定法,流式细胞术和western印迹分析来检查细胞增殖,侵袭,凋亡和细胞周期停滞。此外,皮下肿瘤小鼠模型用于研究NDRG1对体内神经胶质瘤细胞生长的影响。 NDRG1的过表达可抑制U87 MG胶质瘤细胞的增殖和侵袭,并诱导其凋亡,而NDRG1的下调增加了SHG-44胶质瘤细胞的增殖,抑制了凋亡并促进了侵袭。此外,在皮下肿瘤小鼠模型中,NDRG1在U-87 MG细胞中的过表达抑制了体内的致瘤性。本研究的结果表明,NDRG1是抑制神经胶质瘤发生所必需的。因此,靶向NDRG1及其下游靶点可能代表了治疗神经胶质瘤的新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号